PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Overview Fund Activity
Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

92 hedge funds and large institutions have $155M invested in Poseida Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+2
Holders Change %
+2.22%
% of All Funds
1.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
14
Increased
38
Reduced
22
Closed
12
Calls
$1.32M
Puts
$175K
Net Calls
+$1.15M
Net Calls Change
+$445K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$2.5M
2
State Street
State Street
Massachusetts
$4.88M
3
William Blair & Company
William Blair & Company
Illinois
$3.22M
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
$1.18M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
$2.71M

Top Sellers

1
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$644K
2
AI
Atom Investors
Texas
$1.16M
3
Jane Street
Jane Street
New York
$319K
4
Morgan Stanley
Morgan Stanley
New York
$1.06M
5
AGP
Artia Global Partners
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
101
Bayesian Capital Management
New York
– -$32.5K -10,200 Closed
MLICM
102
Metropolitan Life Insurance Company (MetLife)
New York
– -$5.8K -1,817 Closed
AWM
103
Avior Wealth Management
Nebraska
– -$41 -13 Closed
1 2 3 4
5